Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1991-5-31
pubmed:abstractText
Apolipoprotein C-III is a major protein constituent of triglyceride rich lipoproteins and HDL. It occurs in plasma in three isoforms differing by their sialic acid content. Apo C-III putatively inhibits lipolysis and the apo E mediated hepatic uptake of remnants from triglyceride rich particles. We identified a heterozygous carrier of an apolipoprotein C-III variant by the presence of additional bands after isoelectric focusing (IEF) of VLDL. Structural analysis of the variant protein by HPLC, time-of-flight secondary ion mass spectrometry, and automated gas phase sequencing revealed a lysine to glutamic acid replacement in position 58. The underlying A to G exchange was verified by direct sequencing subsequent to amplification by polymerase chain reaction of exon 4 of the apo C-III gene. Family studies revealed vertical transmission of this defect. The two variant carriers exhibited plasma concentrations of HDL cholesterol and apo A-I above the 95th percentiles of sex matched controls whereas the unaffected father and sister showed normal values. The plasma concentrations of apo C-III in the two variant carriers were decreased by 30-40% compared with those of the two unaffected family members and to random controls. Using two-dimensional immunoelectrophoresis as well as IEF and subsequent scanning densitometry, we found that the low serum concentration of apo C-III was a consequence of diminished concentrations of the variant apo C-III isoproteins in both VLDL (15% of normal) and HDL (25% of normal). Apo C-III(Lys58----Glu) heterozygotes possessed unusual HDL as demonstrated by nondenaturing gradient gel electrophoresis. They consisted mainly of HDL2b and contained a proportion of atypically large particles, enriched in apo E, with a Stokes diameter of 13-18 nm and resembling HDLc. In conclusion, heterozygosity for a structural apo C-III variant--apo C-III(Lys58----Glu)--was identified in two hyperalphalipoproteinemic subjects characterized by the presence of low plasma apo C-III concentrations and atypically large HDL.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-13252080, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-165752, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-182536, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-1898657, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-200260, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-208636, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-226638, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2351649, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2506176, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2512329, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2586614, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2614277, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2677733, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2892216, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2916556, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2956259, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2982866, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2985608, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2989400, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-2999980, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3026486, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3091746, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3095375, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3118360, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3123586, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3148681, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3174659, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3192519, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3292686, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3372539, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3410462, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3571400, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3724517, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3739751, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3867663, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-388439, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3934306, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-3937535, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4020294, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4114358, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4337382, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4345202, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4355035, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4358939, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4358940, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4846755, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-4981584, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-5057882, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-5127429, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-5482770, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-6165257, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-6328445, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-6358403, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-6439535, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-6809883, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-6813412, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-7078608, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-7295752, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-7354132, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-7390493, http://linkedlifedata.com/resource/pubmed/commentcorrection/2022742-7410365
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1724-31
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
More...